Homotypic fibrillization of TMEM106B across diverse neurodegenerative diseases.
Chang, A., Xiang, X., Wang, J., Lee, C., Arakhamia, T., Simjanoska, M., Wang, C., Carlomagno, Y., Zhang, G., Dhingra, S., Thierry, M., Perneel, J., Heeman, B., Forgrave, L.M., DeTure, M., DeMarco, M.L., Cook, C.N., Rademakers, R., Dickson, D.W., Petrucelli, L., Stowell, M.H.B., Mackenzie, I.R.A., Fitzpatrick, A.W.P.(2022) Cell 185: 1346-1355.e15
- PubMed: 35247328 
- DOI: https://doi.org/10.1016/j.cell.2022.02.026
- Primary Citation of Related Structures:  
7U0Z, 7U10, 7U11, 7U12, 7U13, 7U14, 7U15, 7U16, 7U17, 7U18 - PubMed Abstract: 
Misfolding and aggregation of disease-specific proteins, resulting in the formation of filamentous cellular inclusions, is a hallmark of neurodegenerative disease with characteristic filament structures, or conformers, defining each proteinopathy. Here we show that a previously unsolved amyloid fibril composed of a 135 amino acid C-terminal fragment of TMEM106B is a common finding in distinct human neurodegenerative diseases, including cases characterized by abnormal aggregation of TDP-43, tau, or α-synuclein protein ...